In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Master File in Korea (CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER. The MFDS reviews the CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER KDMF as part of the drug registration process and uses the information provided in the CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER KDMF to evaluate the safety and efficacy of the drug.
After submitting a CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER suppliers with KDMF on PharmaCompass.